Clinical Trial Detail

NCT ID NCT01765582
Title STEAM: A Study of Sequential and Concurrent FOLFOXIRI/Avastin (Bevacizumab) Regimens Versus FOLFOX/Avastin in First-Line in Patients With Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

colorectal cancer

Therapies

Capecitabine + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Bevacizumab

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult

No variant requirements are available.